相关实验视频
Updated: May 24, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
433
病的进展:病原和治疗目标
Vincent Boima1, Alex Baafi Agyekum2, Khushali Ganatra3
1Department of Medicine and Therapeutics, University of Ghana Medical School, College of Health Sciences, University of Ghana, Accra, Ghana.
Frontiers in medicine
|March 3, 2025
概括
慢性病 (CKD) 涉及炎症和代谢压力,导致末期病 (ESKD). 新兴疗法针对新的分子机制,如APOL1基因变异,以减缓CKD的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 慢性病 (CKD) 是一个全球性的健康问题,患病率越来越高.
- 慢性病进展为末期病 (ESKD) 与传统的风险因素 (肥胖,高血压,糖尿病) 和代谢问题 (胰岛素耐药性,失脂血症,高尿血症) 有关.
- 功能下降加剧死亡率和并发症,特别是心血管并发症,需要ESKD患者进行置换疗法.
研究的目的:
- 审查最近的基底是CKD的分子机制.
- 探索新兴的治疗点来减缓CKD的进展.
主要方法:
- 对CKD中分子通路的当前文献的综述.
- 对新型遗传因素及其与病风险相关性的分析.
- 评估新兴的治疗策略.
主要成果:
- 慢性瘤的发病包括持续的低度炎症,氧化应激,内皮功能障碍和矿物质代谢的改变.
- 微生物组失调和阿波利波蛋白L1 (APOL1) 基因突变是影响脏疾病的新型机制.
- 高风险的APOL1等位基因与ESKD风险增加有关,特别是在非洲血统的人群中.
结论:
- 了解像APOL1变体这样的新型分子机制对于解决CKD差异至关重要.
- 新兴疗法,包括SGLT2抑制剂和APOL1向剂,为控制CKD进展提供了新的途径.
相关概念视频
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Kidney Structure
68.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.5K
Nephrons
2.0K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
Heart Failure Drugs: Diuretics
324
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54

